GlassScriptPhysician profile
Matthew Aaron Causey
NPI 1710479738
$1,198.64
in general payments reported to CMS, 2019-2025
17 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.47 · 2020: $46.05 · 2021: $97.39 · 2022: $151 · 2023: $128 · 2024: $312 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $877.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $181.30 | 2020-2023 | |
| Regeneron Healthcare Solutions, INC. | $145.22 | 2023-2025 | Eylea Hd, Eylea |
| Tarsus Pharmaceuticals, INC. | $138.06 | 2024-2025 | Xdemvy |
| Amgen INC. | $113.04 | 2024 | Tepezza |
| Alcon Vision LLC | $100.26 | 2019-2024 | Rocklatan |
| Harrow Eye, LLC | $99.49 | 2024-2025 | Vevye |
| Abbvie INC. | $67.37 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $59.57 | 2021-2025 | |
| Astellas Pharma US INC | $58.74 | 2025 | Izervay |
| Genentech USA, INC. | $57.43 | 2025 | Vabysmo |
| Apellis Pharmaceuticals, INC. | $38.55 | 2023 | Syfovre |
| Horizon Therapeutics Plc | $33.97 | 2023 | Tepezza |
| Biotissue Holdings INC. | $29.14 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $25.61 | 2020-2021 | |
| Alimera Sciences, INC. | $19.16 | 2024 | Iluvien, Yutiq |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $15.96 | 2025 | Oxervate |
| Shire North American Group INC | $15.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Causey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.